Global Gout Therapeutics Market Study 2016-2026, by Segment (NSAIDs, Corticosteroids, … …), by Market (Hospital Pharmacies, Retail Pharmacies, … …), by Company (AstraZeneca, Takeda Pharmaceuticals, … …)
SKU ID :99ST-14597057 | Published Date: 11-Oct-2019 | No. of pages: 65Description
Summary
The global Gout Therapeutics market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
NSAIDs
Corticosteroids
Colchicine
Urate-Lowering Agents
Others
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
AstraZeneca
Takeda Pharmaceuticals
Horizon Pharma
Merck
Novartis
Sanofi
GlaxoSmithKline
Eli Lilly
Boehringer Ingelheim
Novo Nordisk
LG Life Sciences
Antares Pharma
Astellas Pharma
Eisai
JW Pharmaceutical
Teijin Pharma
Vertex Pharmaceuticals
Sandoz
Regeneron Pharmaceuticals
CymaBay Therapeutics
Ablynx
North America
Europe
Asia-Pacific
South America
Middle East & Africa
The global Gout Therapeutics market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
NSAIDs
Corticosteroids
Colchicine
Urate-Lowering Agents
Others
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Company Coverage (Sales data, Main Products & Services etc.):
AstraZeneca
Takeda Pharmaceuticals
Horizon Pharma
Merck
Novartis
Sanofi
GlaxoSmithKline
Eli Lilly
Boehringer Ingelheim
Novo Nordisk
LG Life Sciences
Antares Pharma
Astellas Pharma
Eisai
JW Pharmaceutical
Teijin Pharma
Vertex Pharmaceuticals
Sandoz
Regeneron Pharmaceuticals
CymaBay Therapeutics
Ablynx
Major Region
MarketNorth America
Europe
Asia-Pacific
South America
Middle East & Africa
TOC
Tables & Figures
Companies
- PRICE
-
$1800$3600Buy Now